Article
Level of an advanced glycated end product is genetically determined: a study of normal twins.
Diabetes - 1 Sept 2003
Leslie R David G, Beyan Huriya, Sawtell Pam, Boehm Bernard O, Spector Tim D, Snieder Harold
Abstract excerpt
Reducing sugars react with amino groups in proteins, lipids, and nucleic acids to produce advanced glycation end products (AGEs), including N(epsilon)-carboxymethyl lysine (CML), which have been implicated in oxidative stress and vascular damage. The aim of this study was to determine whether genetic factors influence serum CML levels in normal subjects. We performed a classical twin study of CML in healthy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
